Nocturnal Parkinson’s Disease Symptoms Study Group
Overview
To study associate factor of Noctural Parkinson's Disease Symptoms and quality of life in Parkinson's disease patients and caregivers.
Full Title of Study: “Nocturnal Parkinson’s Disease Symptoms Study Group”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: August 2013
Interventions
- Other: Questionaire to assess Noctural Parkinson’s Disease Symptoms
- Questionaire to assess Noctural Parkinson’s Disease Symptoms and quality of life
Arms, Groups and Cohorts
- Questionniare
Clinical Trial Outcome Measures
Primary Measures
- To assess Noctural Parkinson’s Disease Symptoms
Secondary Measures
- To assess quality of life in Parkinson’s Disease patient
- To assess quality of life in caregiver of Parkinson’s Disease patient
Participating in This Clinical Trial
Inclusion Criteria
Idiopathic Parkinson's disease patient Exclusion Criteria:
1. Patient with Secondary Parkinsonism eg.Drug-induced Parkinsonism, Vascular Parkinsonism, exposure to toxin, Encephalitis 2. Patient with Atypical Parkinsonial Syndromes eg. Parkinson-plus syndrome, Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD) 3. Patient with Heredodegenerative parkinsonism eg. Spinocerebellar ataxias, Wilson's disease, Juvenile Huntington's disease
Gender Eligibility: All
Minimum Age: 30 Years
Maximum Age: 90 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Chulalongkorn University
- Provider of Information About this Clinical Study
- Principal Investigator: Roongroj Bhidayasiri, Associate Professor – Chulalongkorn University
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.